Epstein Secrets

ing on `unsustainable drug prices' concludes — Hybrid hearing on `Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM * Tom Lantos Human

Dana Deasy said, "We're doing a lot of work with the services on getting them prepared to move their [software] development processes and cycles to DevOps so when the [Joint Enterprise Defense Infrastructure] cloud finally does get awarded, we're not starting at Day One." The JEDI cloud is an "importa

ing on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

Dana Deasy said, "We're doing a lot of work with the services on getting them prepared to move their [software] development processes and cycles to DevOps so when the [Joint Enterprise Defense Infrastructure] cloud finally does get awarded, we're not starting at Day One." The JEDI cloud is an "importa

ring on `unsustainable drug prices' concludes - Hybrid hearing on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

Dana Deasy said, "We're doing a lot of work with the services on getting them prepared to move their [software] development processes and cycles to DevOps so when the [Joint Enterprise Defense Infrastructure] cloud finally does get awarded, we're not starting at Day One." The JEDI cloud is an "importan

ng on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

Dana Deasy said, "We're doing a lot of work with the services on getting them prepared to move their [software] development processes and cycles to DevOps so when the [Joint Enterprise Defense Infrastructure] cloud finally does get awarded, we're not starting at Day One." The JEDI cloud is an "importan